Non-viral, non-nuclease genome-engineering platforms enabling precise, durable insertion of large genetic payloads into defined genomic loci while avoiding double-strand breaks and error-prone repair. Supports therapeutic developers, agricultural and industrial biotech firms, and government agencies with scalable, high-efficiency gene-addition infrastructure via licensing and partnerships.